Previous findings from our and other groups had demonstrated that upstream pharmacological inhibition [22,42,43,44] and stable lentiviral depletion [17,21,23] of Stat3 provokes great antitumoral responses in vitro and improves survival of tumor-bearing mice in vivo. The gene discussed is STAT3; the disease is neoplasm.